Tumor-infiltrating macrophages influence the glycosphingolipid composition of murine brain tumors

Journal of Lipid Research

Volumn 39, Issue 11, 1998, Pages 2218-2227

  Ecsedy, Jeffrey A ^a   Yohe, Herbert C ^b,c   Bergeron, Alan J ^b   Seyfried, Thomas N ^a  

^a BOSTON COLLEGE   (United States)

^b Department of Veterans Affairs Regional Office White River Junction   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Asialo GM1; Astrocytoma; Cancer; CD11b; Ganglioside; GD1 ; Glycolipid; GM1b; Immunotherapy; Mac 1; Macrophage

Indexed keywords

CERAMIDE; GALACTOSE; GANGLIOSIDE; GLYCOSPHINGOLIPID; N ACETYLNEURAMINIC ACID; N GLYCOLOYLNEURAMINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN TUMOR; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INFILTRATION; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; LIPID COMPOSITION; MACROPHAGE ACTIVATION; METABOLIC REGULATION; MOUSE; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; BRAIN NEOPLASMS; CELL SEPARATION; CHROMATOGRAPHY, THIN LAYER; G(M3) GANGLIOSIDE; GLYCOSPHINGOLIPIDS; LEUKEMIC INFILTRATION; MACROPHAGE-1 ANTIGEN; MICE; MICE, INBRED C57BL; RECEPTORS, FC;

EID: 0031724272     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Wood, G. W., and R. A. Morantz. 1979. Immunohistologic evaluation of the lymphoreticular infiltrate of human central nervous system tumors. J. Natl. Cancer Inst. 62: 485-491.
2. Rossi, M. L., J. T. Hughes, M. M. Esiri, H. B. Coakham, and D. B. Brownell. 1987. Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol. Berl. 74: 269-277.
3. Leenstra, S., D. Troost, P. K. Das, N. Claessenk, A. E. Becker, and A. Bosch. 1993. Endothelial cell marker PAL-E reactivity in brain tumor, developing brain, and brain disease. Cancer. 72: 3061-3067.
4. Seyfried, T. N., M. El-Abbadi, and M. L. Roy. 1992. Ganglioside distribution in murine neural tumors. Mol. Chem. Neuropathol. 17: 147-167.
5. El-Abbadi, M., and T. N. Seyfried. 1994. Influence of growth environment on the ganglioside composition of an experimental mouse brain tumor. Mol. Chem. Neuropathol. 21: 273-285.
6. Seyfried, T. N., M. El-Abbadi, J. A. Ecsedy, H. W. Bai, and H. C. Yohe. 1996. Influence of host cell infiltration on the glycolipid content of mouse brain tumors. J. Neurochem. 66: 2026-2033.
7. Ecsedy, J. A., M. G. Manfredi, H. C. Yohe, and T. N. Seyfried. 1997. Ganglioside biosynthetic gene expression in experimental mouse brain tumors. Cancer Res. 57: 1580-1583.
8. Mercurio, A. M., G. A. Schwarting, and P. W. Robbins. 1984. Glycolipids of the mouse peritoneal macrophage. Alterations in amount and surface exposure of specific glycolipid species occur in response to inflammation and tumoricidal activation. J. Exp. Med. 160: 1114-1125.
9. Yohe, H. C., D. L. Coleman, and J. L. Ryan. 1985. Ganglioside alterations in stimulated murine macrophages. Biochim. Biophys. Acta. 818: 81-86.
10. Yohe, H. C., Y. Song, B. B. Reinhold, and V. N. Reinhold. 1997. Structural characterization of the disialoganglioside of murine peritoneal macrophages. Glycobiology. 4: 1215-1227.
11. Macala, L. J., and H. C. Yohe. 1995. In situ accessibility of murine macrophage gangliosides. Glycobiology. 5: 67-75.
12. Fishman, P. H. 1986. Recent advances in identifying the functions of gangliosides. Chem. Phys. Lipids. 42: 137-151.
13. Muthing, J., H. Egge, B. Kniep, and P. F. Muhlradt. 1987. Structural characterization of gangliosides from murine T lymphocytes. Eur. J. Biochem. 163: 407-416.
14. Berenson, C. S., M. A. Patterson, M. A. Pattoli, and T. F. Murphy. 1996. A monoclonal antibody to human macrophage gangliosides inhibits macrophage migration. J. Leukocyte Biol. 59: 371-379.
15. Morrison, W. J., K. Young, H. Offner, and A. A. Vandenbark. 1993. Ganglioside (GM1) distinguishes the effects of CD4 on signal transduction through the TCR/CD3 complex in human lymphocytes. Cell. Mol. Biol. Res. 39: 159-165.
16. Yates, A. J., and A. Rampersaud. 1998. Sphingolipids as receptor modulators. Ann. NY. Acad. Sci. 845: 57-72.
17. Stout, R. D., G. A. Schwarting, and J. Suttles. 1987. Evidence that expression of asialo-GM1 may be associated with cell activation. Correlation of asialo-GM1 expression with increased total cellular RNA and protein content in normal thymocyte and spleen cell populations. J. Immunol. 139: 2123-2129.
18. Yohe, H. C., and J. L. Ryan. 1986. Ganglioside expression in macrophages from endotoxin responder and nonresponder mice. J. Immunol. 137: 3921-3927.
19. Yohe, H. C., C. L. Cuny, L. J. Macala, M. Saito, W. J. McMurray, and J. L. Ryan. 1991. The presence of sialidase-sensitive sialosylgangliotetraosyl ceramide (GM1b) in stimulated murine macrophages. Deficiency of GM1b in Escherichia coli-activated macrophages from the C3H/HeJ mouse. J. Immunol. 146: 1900-1908.
20. Hakomori, S. 1985. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res. 45: 2405-2414.
21. Wikstrand, C. J., D. C. Longee, R. E. McLendon, G. N. Fuller, H. S. Friedman, P. Fredman, L. Svennerholm, and D. D. Bigner. 1993. Lactotetraose series ganglioside 3′,6′-isoLD1 in tumors of central nervous and other systems in vitro and in vivo. Cancer Res. 53: 120-126.
22. Sung, C. C., D. K. Pearl, S. W. Coons, B. W. Scheithauer, P. C. Johnson, and A. J. Yates. 1994. Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors. Cancer. 74: 3010-3022.
23. Ecsedy, J. A., H. C. Yohe, and T. N. Seyfried. 1997. Glycosphingolipid composition of tumor infiltrating macrophages isolated from murine brain tumors. J. Neurochem. 66 (Suppl.): S12 (Abstract).
24. Ecsedy, J. A., H. C. Yohe, A. J. Bergeron, and T. N. Seyfried. 1998. Glycosphingolipid composition of tumor-infiltrating macrophages in brain tumors. Proc. Am. Assoc. Cancer Res. 39: 211.
25. Flavin, H. J., A. Wieraszako, and T. N. Seyfried. 1991. Enhanced aspartate release from hippocampal slices of epileptic (E1) mice. J. Neurochem. 56: 1007-1011.
26. Seyfried, T. N., R. K. Yu, M. Saito, and M. Albert. 1987. Ganglioside composition of an experimental mouse brain tumor. Cancer Res. 47: 3538-3542.
27. Evans, R. 1977. Effect of X-irradiation on host-cell infiltration and growth of a murine fibrosarcoma. Br. J. Cancer. 35: 557-566.
28. Seyfried, T. N., G. H. Glaser, and R. K. Yu. 1978. Cerebral, cerebellar, and brain stem gangliosides in mice susceptible to audiogenic seizures. J. Neurochem. 31: 21-27.
29. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
30. Brigangde, J. V., F. M. Platt, and T. N. Seyfried. 1998. Inhibition of glycosphingolipid biosynthesis does not impair growth or morphogenesis of the postimplantation mouse embyro. J. Neurochem. 70: 871-882.
31. Seyfried, T. N., and T. Ariga. 1992. Neutral glycolipid abnormalities in a t-complex mutant mouse embryo. Biochem. Genet. 30: 557-565.
32. Kean, E. L. 1996. Separation of gluco- and galactocerebrosides by means of borate thin-layer chromatograpy. J. Lipid Res. 7: 449-452.
33. Saito, M., N. Kasai, and R. K. Yu. 1985. In situ immunological determination of basic carbohydrate structures of gangliosides on thin-layer plates. Anal. Biochem. 148: 54-58.
34. Evans, R., and E. M. Lawler. 1980a. Macrophage content and immunogenicity of C57BL/6J and BALB/cByJ methylcholanthrene-induced sarcomas. Int. J. Cancer. 26: 831-835.
35. Muthing, J., B. Schwinzer, J. Peter-Katalinic, H. Egge, and P. F. Muhlradt. 1989. Gangliosides of murine T lymphocyte subpopulations. Biochemistry. 28: 2923-2929.
36. Safdari, H., F. H. Hochberg, and E. Richardson, Jr. 1985. Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas. Surg. Neurol. 23: 221-226.
37. Rossi, M. L., N. R. Jones, E. Candy, J. A. Nicoll, J. S. Compton, J. T. Hughes, M. M. Esiri, T. H. Moss, F. F. Cruz-Sanchez, and H. B. Coakham. 1989. The mononuclear cell infiltrate compared with survival in high-grade astrocytomas. Acta Neuropathol. Berl. 78: 189-193.
38. Arosarena, O., C. Guerin, H. Brem, and J. Laterra. 1994. Endothelial differentiation in intracerebral and subcutaneous experimental gliomas. Brain Res. 640: 98-104.
39. Seyfried, T. N., M. El-Abbadi, J. A. Ecsedy, and H. C. Yohe. 1998. Ganglioside composition of a mouse brain tumor grown in the severe combined immunodeficiency (SCID) mouse. Mol. Chem. Neuropathol. 33: 27-37.
40. Kawashima, I., H. Ozawa, M. Kotani, M. Suzuki, T. Kawano, M. Gomibuchi, and T. Tai. 1993. Characterization of ganglioside expression in human melanoma cells: immunological and biochemical analysis. J. Biochem. Tokyo. 114: 186-193.
41. Schackert, G., R. D. Simmons, T. M. Buzbee, D. A. Hume, and I. J. Fidler. 1988. Macrophage infiltration into experimental brain metastases: occurrence through an intact blood-brain barrier. J. Natl. Cancer Inst. 80: 1027-1034.
42. Leek, R. D., C. E. Lewis, R. Whitehouse, M. Greenall, J. Clarke, and A. L. Harris. 1996. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56: 4625-4629.
43. Taki, T., D. Ishikawa, M. Ogura, M. Nakajima, and S. Handa. 1997. Ganglioside GD1alpha functions in the adhesion of metastatic tumor cells to endothelial cells of the target tissue. Cancer Res. 57: 1882-1888.
44. Kasai, M., M. Iwamori, Y. Nagai, K. Okumura, and T. Tada. 1980. A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol. 10: 175-180.
45. Seyfried, T. N., A. M. Novikov, R. A. Irvine, and J. V. Brigande. 1994. Ganglioside biosynthesis in mouse embryos: sialyltransferase IV and the asialo pathway. J. Lipid Res. 35: 993-1001.
46. Khazaeli, M. B., R. M. Conry, and A. F. LoBuglio. 1994. Human immune response to monoclonal antibodies. J. Immunother. 15: 42-52.
47. Kurpad, S. N., C. J. Wikstrand, and D. D. Bigner. 1994. Immunobiology of malignant astrocytomas. Semin. Oncol. 21: 149-161.
48. Uttenreuther-Fischer, M. M., C. S. Huang, and A. L. Yu. 1995. Pharmacokinetics of human-mouse chimeric anti-GD2 mAb ch14.18 in a phase I trial in neuroblastoma patients. Cancer Immunol. Immunother. 41: 331-338.
49. Pancook, J. D., J. C. Becker, S. D. Gillies, and R. A. Reisfeld. 1996. Eradication of established hepatic human neuroblastoma metastases in mice with severe combined immunodeficiency by antibody-targeted interleukin-2. Cancer Immunol. Immunother. 42: 88-92.